183 related articles for article (PubMed ID: 21477379)
1. Elevated expression of CDK4 in lung cancer.
Wu A; Wu B; Guo J; Luo W; Wu D; Yang H; Zhen Y; Yu X; Wang H; Zhou Y; Liu Z; Fang W; Yang Z
J Transl Med; 2011 Apr; 9():38. PubMed ID: 21477379
[TBL] [Abstract][Full Text] [Related]
2. Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.
Liu Z; Long X; Chao C; Yan C; Wu Q; Hua S; Zhang Y; Wu A; Fang W
BMC Cancer; 2014 Apr; 14():274. PubMed ID: 24751144
[TBL] [Abstract][Full Text] [Related]
3. [Cytoplasmic expression of CDK4 protein and its correlation with the clinicopathologic features and prognosis of lung cancer].
Zhang Y; Zhou Y; Liu Z; Fang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1572-5. PubMed ID: 23174577
[TBL] [Abstract][Full Text] [Related]
4. miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
Zhu W; Yu Y; Fang K; Xiao S; Ni L; Yin C; Huang X; Wang X; Zhang Y; Le HB; Cui R
Cancer Med; 2023 Feb; 12(4):4590-4604. PubMed ID: 36172919
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell transforming sequence 2 in human oral cancer.
Iyoda M; Kasamatsu A; Ishigami T; Nakashima D; Endo-Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2010 Nov; 5(11):e14082. PubMed ID: 21124766
[TBL] [Abstract][Full Text] [Related]
6. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
7. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
[TBL] [Abstract][Full Text] [Related]
8. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
[TBL] [Abstract][Full Text] [Related]
9. miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
Lang B; Zhao S
Oncol Rep; 2018 Jan; 39(1):71-80. PubMed ID: 29115564
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.
Hu W; Wei H; Li K; Li P; Lin J; Feng R
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28597490
[TBL] [Abstract][Full Text] [Related]
11. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of RCC1 sensitizes immunotherapy by up-regulating PD-L1 via p27
Zeng X; Zhong M; Yang Y; Wang Z; Zhu Y
J Cell Mol Med; 2021 Apr; 25(8):4136-4147. PubMed ID: 33630417
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
15. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
16. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
Li D; Li DQ; Liu D; Tang XJ
Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
[TBL] [Abstract][Full Text] [Related]
17. [Expression and roles of CDK4 and p21 in lung tissues of premature rats with hyperoxia-induced chronic lung disease].
Gao Y; Xue XD; Li JY; Wang N
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):595-600. PubMed ID: 18082050
[TBL] [Abstract][Full Text] [Related]
18. KLF5 promotes proliferation in gastric cancer via regulating p21 and CDK4.
Chen P; Qian XK; Zhang YF; Sun XG; Shi XJ; Gao YS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4224-4231. PubMed ID: 32373958
[TBL] [Abstract][Full Text] [Related]
19. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
20. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]